A Basic-clinical Translational Research in Hepatitis B Virus (HBV)-Specific Antigen Peptides and HepG2 Cell Lysate Co-activated Dendritic Cells Combined With Transarterial Chemoembolization (TACE) in HBV-related HCC Treatment (BTRHBVAPHCLCDCCTCHBVHCCT)
Clinical trial NCT03086564 · COMPLETED
Trial details
- NCT number
- NCT03086564
- Sponsor
- Yuehua Huang
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-01
- Primary completion
- 2020-05-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.